© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Nov 22, 2014, the consensus forecast amongst 3 polled investment analysts covering GW Pharmaceuticals plc advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Jul 28, 2014. The previous consensus forecast advised investors to purchase equity in GW Pharmaceuticals plc.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 2 analysts offering 12 month price targets for
Dividend information is not available for
On Aug 06, 2014,
The next earnings announcement is expected on Nov 17, 2014. View Full Interim Financials
|Average growth rate||-28.00%|
|Average growth rate||+44.05%|
GW Pharmaceuticals plc had 3rd quarter 2014 revenues of 7.61m. This missed the 467.84m consensus estimate of the 3 analysts following the company. This was 1.12% above the prior year's 3rd quarter results. View Full Interim Financials
|Average growth rate||+0.83%|
GW Pharmaceuticals plc had revenues for the full year 2013 of 27.30m. This was 17.59% below the prior year's results. View Full Annual Financials
|Average growth rate||+4.49%|